Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Brazilian Modeling of COVID-19(BRAM-COD): a Bayesian Monte Carlo approach for COVID-19 spread in a limited data set context

Samy Dana, View ORCID ProfileAlexandre B. Simas, Bruno A. Filardi, Rodrigo N. Rodriguez, View ORCID ProfileLeandro da Costa Lane Valiengo, View ORCID ProfileJose Gallucci-Neto
doi: https://doi.org/10.1101/2020.04.29.20081174
Samy Dana
1Fundação Getúlio Vargas, Sao Paulo, Brazil (EASP-FGV)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre B. Simas
2Mathematics Department, Federal University of Paraíba, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexandre B. Simas
Bruno A. Filardi
3Scientific Director of Cancer Institute, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodrigo N. Rodriguez
4Director of Ubarana Hospital, Taubaté, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leandro da Costa Lane Valiengo
5University of São Paulo Medical School, Institute and Department of Psychiatry, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Leandro da Costa Lane Valiengo
Jose Gallucci-Neto
5University of São Paulo Medical School, Institute and Department of Psychiatry, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jose Gallucci-Neto
  • For correspondence: galluccineto@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

1 ABSTRACT

Background The new coronavirus respiratory syndrome disease (COVID-19) pandemic has become a major health problem worldwide. Many attempts have been devoted to modeling the dynamics of new infection rates, death rates, and the impact of the disease on health systems and the world economy. Most of these modeling concepts use the Susceptible-Infectious-Susceptible (SIS) and Susceptible-Exposed-Infected-Recovered (SEIR) compartmental models; however, wide imprecise outcomes in forecasting can occur with these models in the context of poor data, low testing levels, and a nonhomogeneous population.

Objectives To predict Brazilian ICU beds demand over time and during COVID-19 pandemic “peak”.

Methods In the present study, we describe a Bayesian COVID-19 model combined with a Hamiltonian Monte Carlo algorithm to forecast quantitative predictions of infections, number of deaths and the demand for critical care beds in the next month in the Brazilian context of scarce data availability. We also estimated COVID-19 spread tendency in the state of São Paulo and forecasted the demand for critical care beds, as São Paulo is the epicenter of the Latin America pandemic.

Results Our model estimated that the number of infected individuals would be approximately 6.5 million (median) on April 25, 2020, and would reach 16 to 17 million (median) by the end of August 2020 in Brazil. The probability that an infected individual requires ICU-level care in Brazil is 0.5833%. Our model suggests that the current level of mitigation seen in São Paulo is sufficient to reach Rt < 1, thus attaining a “peak” in the short term. In São Paulo state, the total number of deaths is estimated to be around 9,000 (median) with the 2.5% quantile being 6,600 deaths and the 97.5% quantile being around 13,350 deaths. Also, São Paulo will not attain its maximum capacity of ICU beds if the current trend persists over the long term.

Conclusions The COVID-19 pandemic should peak in Brazil between May 8 and May 20, 2020 with a fatality rate lower than that suggested in the literature. The northern and northeastern regions of Brazil will suffer from a lack of available ICU beds, the southern and central-western regions appear to have sufficient ICU beds, finally, the southeastern region seems to have enough ICU beds only if it shares private beds with the publicly funded Unified Health System (SUS). The model predicts that, if the current policies and population behavior are maintained throughout the forecasted period, by the end of August 2020, Brazil will have around 7.6% to 8.2% of its population immune to COVID-19.

Competing Interest Statement

Samy Dana works as Head of Content of Easyinvest (investment broker), with no relevant or material financial interests that relate to the work described in this paper. Alexandre B Simas declare that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Bruno Filardi declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Rodrigo N Rodriguez declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Leandro Lane da Costa Valiengo declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Jose Gallucci-Neto declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Funding Statement

Alexandre B. Simas acknowledges the financial support from CNPq.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be available on demand.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Brazilian Modeling of COVID-19(BRAM-COD): a Bayesian Monte Carlo approach for COVID-19 spread in a limited data set context
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Brazilian Modeling of COVID-19(BRAM-COD): a Bayesian Monte Carlo approach for COVID-19 spread in a limited data set context
Samy Dana, Alexandre B. Simas, Bruno A. Filardi, Rodrigo N. Rodriguez, Leandro da Costa Lane Valiengo, Jose Gallucci-Neto
medRxiv 2020.04.29.20081174; doi: https://doi.org/10.1101/2020.04.29.20081174
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Brazilian Modeling of COVID-19(BRAM-COD): a Bayesian Monte Carlo approach for COVID-19 spread in a limited data set context
Samy Dana, Alexandre B. Simas, Bruno A. Filardi, Rodrigo N. Rodriguez, Leandro da Costa Lane Valiengo, Jose Gallucci-Neto
medRxiv 2020.04.29.20081174; doi: https://doi.org/10.1101/2020.04.29.20081174

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4805)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5278)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (765)
  • Public and Global Health (1796)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)